MIRA Pharmaceuticals News

MIRA Pharmaceuticals | 424B5: Prospectus

Sep 28 05:24

MIRA Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Sep 28 04:49

MIRA Pharmaceuticals | 8-K: Current report

Sep 13 04:34

MIRA Pharmaceuticals | 8-K: Current report

Sep 11 04:04

MIRA Pharmaceuticals | 144/A: Others

Sep 7 04:40

MIRA Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 5 08:26

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner McNulty Brian Patrick

Aug 31 04:10

MIRA Pharmaceuticals | 8-K: Current report

Aug 24 04:17

MIRA Pharmaceuticals | EFFECT: Others

Aug 19 18:03

MIRA Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

Aug 17 04:08

MIRA Pharmaceuticals | CORRESP: CORRESP

Aug 16 10:31

MIRA Pharmaceuticals | UPLOAD: Others

Aug 16 10:30

MIRA Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 14 04:08

MIRA Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Aug 12 20:40

MIRA Pharmaceuticals | 8-K: Current report

Aug 10 04:18

MIRA Pharmaceuticals | 8-K: Current report

Aug 8 20:59

MIRA Pharmaceuticals | DEFA14A: Others

Jul 27 05:00

MIRA Pharmaceuticals | DEF 14A: Definitive information statements

Jul 27 04:55

MIRA Pharmaceuticals | 8-K: Current report

Jul 25 04:11

MIRA Pharmaceuticals | 8-K: Current report

Jul 20 05:16